Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?
Hematology Am Soc Hematol Educ Program
; 2013: 283-5, 2013.
Article
em En
| MEDLINE
| ID: mdl-24319192
ABSTRACT
A 5-year-old boy presents with platelet count of 2×10(9)/L and clinical and laboratory evidence of immune thrombocytopenia. He has epistaxis and oral mucosal bleeding. Complete blood count reveals isolated thrombocytopenia without any decline in hemoglobin and he is Rh+. You are asked if anti-D immunoglobulin is an appropriate initial therapy for this child given the 2010 Food and Drug Administration "black-box" warning.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imunoglobulina D
/
Epistaxe
/
Hemorragia Bucal
/
Púrpura Trombocitopênica Idiopática
Tipo de estudo:
Diagnostic_studies
Limite:
Child, preschool
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Hematology Am Soc Hematol Educ Program
Assunto da revista:
HEMATOLOGIA
Ano de publicação:
2013
Tipo de documento:
Article